Misoprostol
Gas Bloat Syndrome
Montefiore Medical CenterSmall moleculeEarly Phase 1Active
C
39/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 24/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Gas Bloat Syndrome cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Albendazole Sheba Medical Center | N/A | D |
TINIDAZOLE Sheba Medical Center | N/A | D |
Same molecule, other indications
Misoprostol is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →